Home > PE Ratio > INNOVA CAPTAB

INNOVA CAPTAB
PE (Price/Earnings) Ratio

The Current P/E Ratio of INNOVA CAPTAB is 39.09.

Share Price ₹876.6May 30,2025
Market Cap ₹5,014.2 Cr
Earnings-TTM₹128.3 CrTTM-Consolidated Results
Price/Earnings39.09xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for INNOVA CAPTAB
Please provide your vote to see the results
INNOVA CAPTAB is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals

Definition & Calculation of PE (Price/Earnings) ratio of INNOVA CAPTAB

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of INNOVA CAPTAB is calculated as :

Current Market Cap [ ₹5,014.2 Cr] as on May 30,2025

(/) Earnings [ ₹128.3 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 39.09x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for INNOVA CAPTAB , the investors are currently willing to pay 39.09 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of INNOVA CAPTAB !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of INNOVA CAPTAB over the last five years.

Historical PE (Price/Earnings) ratio chart of INNOVA CAPTAB


PE Ratio Performance Analysis for INNOVA CAPTAB

- INNOVA CAPTAB 's latest p/e ratio is 39.09x.

- INNOVA CAPTAB 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 5.44x.

- INNOVA CAPTAB 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, INNOVA CAPTAB 's p/e ratio peaked in Mar2024 at 27.18x.

- INNOVA CAPTAB 's p/e ratio hit its five-year low in Mar2023 of 0x.


How does INNOVA CAPTAB 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
INNOVA CAPTAB 128.2639.095,014.2
SUN PHARMACEUTICAL INDUSTRIES LTD10,980.1036.67402,680.0
DIVIS LABORATORIES LTD2,191.0080.12175,532.0
CIPLA LTD5,291.0522.36118,315.0
TORRENT PHARMACEUTICALS LTD1,911.0056.21107,421.0
DR REDDYS LABORATORIES LTD5,703.5018.31104,453.0
MANKIND PHARMA LTD2,003.2250.96102,080.0
ZYDUS LIFESCIENCES LTD4,614.8020.2793,564.7
LUPIN LTD3,306.2627.0589,439.2
AUROBINDO PHARMA LTD3,515.2618.9666,647.0
ABBOTT INDIA LTD1,414.4445.7564,710.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs INNOVA CAPTAB 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.31x
Max industry PE 80.12x
Median industry PE 36.67x
Average industry PE 37.80x



You may also like the below Video Courses